Rostyslav O. Bilyy
Rostyslav O. Bilyy publishes mostly in Immunology, Molecular Biology and Biomedical Engineering, on topics such as Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Glycosylation and Glycoproteins Research and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #1,045,365 of 7,710,434 ranked researchers
- Rank in Ukraine
- #344 of 46,931
- Works
- 176
- Citations
- 6.6k
- Citations per work
- 37.7
What does Rostyslav O. Bilyy research?
Rostyslav O. Bilyy's work is mostly in Immunology and Microbiology (20%), Biochemistry, Genetics and Molecular Biology (18%), Engineering (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else7240.7%
- Life Sciences6637.5%
- Physical Sciences3016.8%
- Engineering158.3%
- Chemistry84.4%
- Materials Science74.1%
- Health Sciences95.0%
- Medicine95.0%
- 1Immunology20% of their works
- 2Molecular Biology18% of their works
- 3Biomedical Engineering8% of their works
- 4Radiology, Nuclear Medicine and Imaging5% of their works
- 5Organic Chemistry4% of their works
- 6Materials Chemistry4% of their works
Research topics
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Glycosylation and Glycoproteins Research
- Monoclonal and Polyclonal Antibodies Research
- Nanoplatforms for cancer theranostics
- Galectins and Cancer Biology
- Phagocytosis and Immune Regulation
- Immunotherapy and Immune Responses
- Inflammasome and immune disorders
Which keywords describe Rostyslav O. Bilyy's research?
The keywords of their largest research topics: Inflammation, Reactive Oxygen Species, Autoimmunity, Glycosylation, Immunity, Cancer, NADPH Oxidases and Neutrophil Extracellular Traps.
- NLRP3
- Dendritic Cells
- apoptotic cells
- Macrophage Activation
- Photothermal Therapy
- Therapeutic Antibodies
- Immune System
- Cancer Immunotherapy
- Neutrophil Extracellular Traps
- Cancer
- Glycosylation
- Reactive Oxygen Species
- Inflammation
- Autoimmunity
- Immunity
- NADPH Oxidases
- Immune Regulation
- Glycans
- Fc Receptors
- Nanoparticles
- Galectins
- CD47
- Antigen Presentation
- Inflammasome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Inflammation543 topics
- Reactive Oxygen Species512 topics
- Autoimmunity452 topics
- Glycosylation432 topics
- Immunity412 topics
- Cancer362 topics
- NADPH Oxidases311 topic
- Neutrophil Extracellular Traps311 topic
- Immune Regulation272 topics
- Cancer Immunotherapy232 topics
- Glycans221 topic
- Immune System221 topic
- Fc Receptors211 topic
- Therapeutic Antibodies211 topic
- Nanoparticles201 topic
- Photothermal Therapy201 topic
- Galectins141 topic
- Macrophage Activation141 topic
- CD47131 topic
- apoptotic cells131 topic
- Antigen Presentation101 topic
- Dendritic Cells101 topic
- Inflammasome91 topic
- NLRP391 topic
Where does Rostyslav O. Bilyy work?
Rostyslav O. Bilyy's main affiliation in the publication record is Danylo Halytsky Lviv National Medical University, Ukraine.
How many publications and citations does Rostyslav O. Bilyy have?
OpenAlex counts 176 works and 6,637 citations for Rostyslav O. Bilyy, an h-index of 34, ranking #1,045,365 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rostyslav O. Bilyy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.